From April 1, 2024 to June 30, 2024, the company has repurchased 1,006,000 shares, representing 0.24% for CNY 27.75 million. With this, the company has completed the repurchase of 1,617,267 shares, representing 0.39% for CNY 44.76 million under the buyback announced on March 12, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.38 CNY | +1.71% | +3.92% | -25.01% |
07-02 | Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024. | CI |
05-20 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.01% | 1.39B | |
+8.54% | 100B | |
+11.97% | 43.89B | |
-11.76% | 33.24B | |
+80.23% | 29.36B | |
-12.20% | 16.08B | |
+4.00% | 14.68B | |
-1.90% | 12.87B | |
+178.17% | 10.55B | |
+3.07% | 8.83B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024.